- Largest-ever Ozempic and GLP-1 drug study finds they lower risk of 42 health conditions, including heart attacks and Alzheimer’s disease Fortune
- Mapping the effectiveness and risks of GLP-1 receptor agonists Nature.com
- Sweeping review suggests weight-loss drugs’ effect on 175 conditions The Washington Post
- Weight-loss jabs linked to reduced risk of 42 conditions including dementia The Guardian
- Ozempic-style drugs tied to more than 60 health benefits and risks in biggest study-of-its-kind Livescience.com